An assessment of 6 placebo-managed medical trials with 1,134 overall individuals concluded that cannabinoids (nabiximols, dronabinol, and THC/CBD) ended up affiliated with a higher regular advancement over the Ashworth scale for spasticity in numerous sclerosis individuals compared with placebo, While this did not get to statistical importance.A Ph